Accenture anticipates full-year revenue growth between 3% and 6%, exceeding analysts' estimates of 3.9%. In the fourth quarter, Accenture r...

India's GST collections remained strong, rising to Rs 2.04 lakh crore in September, however experts express concern over the wide gap in ta...

Inox Air Products has filed IPO papers with Sebi for an issue entirely comprising an OFS of 7.7 crore shares, with no fresh issue component...

Inox Air Products has unveiled a draft red herring prospectus as it seeks to raise substantial funds through an initial public offering. As...

Sector leader Tata Consultancy Services and its nearest rival, Infosys, are projected to report weak numbers for the three months ending Se...

India's top IT firms are bracing for underwhelming earnings as they revise annual revenue growth expectations downward. The duel of AI-indu...

Resistance to chemicals and formulations is an evolving challenge, particularly in crops where the same pest pressures persist over multipl...

Solar Industries is performing well in the market despite broader weaknesses, primarily due to strong earnings. The planned acquisition of ...

India Inc is likely to see a dip in earnings performance for Q2 in comparison to Q1, with analysts forecasting a growth slowdown of roughly...

Anthropic is betting that AI will reshape the global economy more profoundly than industrialization, electricity and the internet, accordin...

As of June 30, 2026, Royal Chain had a product portfolio of more than 27,000 designs. Its offerings are marketed under in-house brands incl...

Surat-based J B Ecotex Ltd has filed its DRHP with SEBI to raise funds through an IPO. The proposed issue comprises a fresh issue of up to ...

Motilal Oswal has initiated coverage on Aster DM Quality Care with a Buy rating and Rs 910 target, citing merger synergies, capacity expans...

Anupam Rasayan India Limited has finalised its acquisition of a controlling interest in Bliss GVS Pharma, marking a strategic expansion int...

The US-German company has acquired a land parcel in Sanand, Gujarat, for establishing its second facility in the region to capitalise on th...

Epigral is planning a target revenue of ₹5000 crore by 2030-31, aided by upcoming production scale-ups in CPVC Resin and Epichlorohyrdin (E...

Partnering with a Singaporean firm, it plans to be the first Indian company to enter the high-growth vertical at a time when chip designing...